ISSN: 2167-7700

Chemotherapy: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year
across USA, Europe & Asia with support from 1000 more scientific Societies and
Publishes 700+ Open Access Journals which contains over 50000
eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers
Each Journal is getting 25,000+ Readers
This Readership is 10 times more when compared to other
Subscription Journals (Source: Google Analytics)
 
 
 
 
 
 

Editorial Board

Claudette Klein

Editor-in-Chief
Claudette Klein
Professor
Biochemistry and Molecular Biology
Saint Louis University

USA

Biography :

Saint Louis University USA

 Biography
Research Interest :

We propose that the novel use of Zn as a chemotherapeutic agent for cancer will significantly improve patient outcome.  We are using prostate cancer and ovarian cancer tissue culture cells to test the generally applicability of Zn as a cancer treatment.  Our research involves evaluating varied means by which we can selectively deliver cytotoxic levels of Zn to cancer cells while sparing non-targeted cells.  Additionally, we are investigating the mechanism by which Zn kills cancer cells with the idea of indentifying new pathways and/or targets for additional drug development.  

 Research Interest
 Network
Randy A. Brown

Randy A. Brown
Professor
Department of Medicine
University of Florida
USA
Tel. 352-273-7832
Fax 352-273-5006

Biography :
 Biography
Research Interest :
 Research Interest
 Network
Wasif Saif M

Wasif Saif M
Professor
College of Physicians and Surgeons
Columbia University
USA
Tel. 212-305-4954
Fax 212-305-3035

Biography :

Columbia University

 Biography
Research Interest :
 Research Interest
 Network
Florian Wagenlehner

Florian Wagenlehner
Professor
Clinic for Urology
Justus-Liebig-University Giessen
Germany

Biography :

Justus-Liebig-University Giessen

 Biography
Research Interest :

Clinical studies
Urinary tract infections
Prostatitis
Antibiotic treatment
Andrology
Prostate cancer

 Research Interest
 Network
Tetsuya Konishi

Tetsuya Konishi
Professor
Department of Functional and Analytical Food Sciences
Niigata University of Pharmacy & Applied Life Sciences
Japan

Biography :

He was graduated from Tokyo College of Pharmacy. AZer completing his graduate study, he worked on radioactive tracer in drug metabolism as a research assistant at Physical pharmacy department. AZer obtained PhD degree in Pharmaceutical sciences, he joined Dr. Lester Packer’s lab as a post‚Äźdoctoral fellow at University of California, Berkeley where he engaged in membrane bioenergetics research on halobacterial rhodopsin. In 1985, he obtained professor position and established radiopharmaceu8cal science lab at Niigata College of Pharmacy where free radical biology and molecular biological researches were developed. 2001, he engaged in establishing Food Science department in NUPALS and started food func8on study using an8oxidant tradi8onal oriental medicine formula as a food model. Current topics of his research are the food func8ons modula8ng DNA damage responses and aging, especially cell cycle checkpoint kinases and their applica8on in Complementary medicine in Cancer treatment. He published more than 150 papers in peer reviewed journal. He served as reviewer, editor of several scien8fic journals and for other social events. He has been chairing Interna8onal Niigata Symposium on Diet and Health since 2004.

 Biography
Research Interest :

Food functions modulating DNA damage responses and aging, especially cell cycle checkpoint kinases and their application in Complementary medicine in Cancer treatment.

 Research Interest
 Network
Ken H. Young

Ken H. Young
Associate Professor
University of Texas
USA
Tel. 713-745-2598
Fax 713-792-7273

Biography :

University of TexasKen H. Young, MD PhD is an Associate Professor in the Department of Hematopathology at the University of Texas MD Anderson Cancer Center. He was Medical Director of Hematology at the University of Wisconsin School of Medicine and University East & West Clinic Laboratories, overseeing the laboratories at the University of Wisconin Hospital and Clinics Core Laboratory. He received his PhD from University of Lund School of Medicine and completed his MD training from Oregon Health Science University. He is board certified in Anatomic and Clinical Pathology and Hematopathology.

 Biography
Research Interest :

His interests are to characterize molecular defects in patients with leukemia and lymphoma by using gene expression profiling, immunophenotypic method, methylation-microRNA-CGH arrays and current NGS molecular technologies with particular interest in tumor suppressor genes, oncogenes, p53 and NF-kB pathways. He has worked extensively on molecular diagnostics for human cancer and has obtained several novel discoveries valuable to predict treatment response, clinical outcome and survival in cancer patients.

 Research Interest
 Network
Zhimin (James) Lu

Zhimin (James) Lu
Associate Professor
Department of Neuro-Oncology
University of Texas
USA
Tel. 713-834-6231
Fax 713-834-6230

Biography :

University of Texas

 Biography
Research Interest :

Tumor cell invasion and metastasis, cancer cell metabolism

 Research Interest
 Network
Ben C. Valdez

Ben C. Valdez
Associate Professor
Department of Stem Cell Transplantation & Cellular Therapy
University of Texas
USA
Tel. 713-745-4370
Fax 713-792-5673

Biography :

Ben C. Valdez, PhD, is an Associate Professor in the Dept of Stem Cell Transplantation and Cellular Therapy at the University of Texas MD Anderson Cancer Center, Houston, Texas. He obtained his PhD in Biochemistry at Louisiana State University and received his post-doctoral training at Baylor College of Medicine.
 

 Biography
Research Interest :

Use of DNA alkylating agents and nucleoside analogs as part of preconditioning therapy prior to hematopoietic stem cell transplantation

 Research Interest
 Network
Partow Kebriaei

Partow Kebriaei
Associate Professor
Department of Stem Cell Transplant and Cellular Therapy
The University of Texas
USA
Tel. 713-745-0663
Fax 713-794-4902

Biography :

The University of TexasDr. Partow Kebriaei is an Associate Professor in the Department of Stem Cell Transplant and Cellular Therapy at the MD Anderson Cancer Center in Houston, Texas. She completed her Hematology and Oncology fellowship training at the University of Chicago, and began her tenure at MD Anderson in 2003. Dr. Kebriaei’s research interests include therapy of leukemias, in particular acute lymphoblastic leukemia, as well as autologous and allogeneic stem cell transplantation for lymphoma and leukemia. She is interested in the development of novel transplant preparative regimens that may have less regimen-related toxicity, and increased disease efficacy. Dr. Kebriaei has authored numerous reviews, book chapters, and papers, and serves as a reviewer for major hematology and oncology publications. She is an active member of hematology and oncology professional societies including American Association for Cancer Research, American Society of Hematology, American Society of Clinical Oncology, and American Society for Blood and Marrow Transplantation.

 Biography
Research Interest :

She is interested in investigating the use of traditional chemotherapeutic agents in combination with cellular therapies and adoptive immunotherapy to develop more effective treatment regimens.  Work toward this aim includes investigating the use CD19-directed T cell therapy for lymphoid malignancies, using umbilical cord blood in combination with a standard allogeneic peripheral blood stem cell transplant to augment the graft versus leukemia effect, and investigating the use of mesenchymal stem cells for the therapy of graft versus host disease. 

 Research Interest
 Network
Gary L. Johanning

Gary L. Johanning
Associate Professor
University of Texas
USA
Tel. 512-332-5211
Fax 512-332-7375

Biography :

Gary L. Johanning, MS, PhD, is an Associate Professor of Comparative Medicine at the Michale E. Keeling Center for Comparative Medicine and Research with the University of Texas MD Anderson Cancer Center at Bastrop TX.  He received his B.S., M.S. and PhD in Biochemistry from the University of Missouri at Columbia and completed a postdoctoral fellowship in the Biochemistry Department at Case Western Reserve University.  He is an Editorial Board Member of Cancer Management and Research and The Open Lung Cancer Journal, and is Associate Editor of Nutrition and Dietary Supplements. He has been awarded grants from the National Institutes of Health, the Department of Defense and several foundations.  He is a member of the Executive Committee of The Nutritional Sciences Council. His primary research interests include micronutrients and their effect on chemotherapy efficacy, nutrition and cancer, endogenous retroviruses, and cancer prevention and immunotherapy. 

 Biography
Research Interest :

A major goal of the research in Dr. Johanning’s laboratory is to determine the role of the vitamin folic acid (folate) in carcinogenesis, cancer prevention, and immune response. An important aspect of this research is evaluating the influence of folic acid on the development of resistance to cisplatin and other chemotherapeutic agents. Cancer cells can become resistant to the cytotoxic action of chemotherapeutic agents either at the outset (intrinsic resistance) or after the agents are administered for a period of time (acquired resistance). Resistance to cisplatin and other agents is an important problem in cancer therapy, and the mechanism by which resistance develops is not clear. Dr. Johanning has obtained data indicating that folic acid can prevent the development of both intrinsic and acquired resistance to cisplatin in lung and ovarian cancer cell lines.

 Research Interest
 Network
Cheng Cameron Yin

Cheng Cameron Yin
Associate Professor
Department of Hematopathology
The University of Texas
USA
 

Biography :

The University of TexasUpon completion of a MD at Beijing Medical University and a PhD in Pathology at the University of Wisconsin-Madison, Dr. Yin pursued her clinical residency training in Anatomic and Clinical Pathology, followed by two fellowships in Hematopathology and Molecular Genetic Pathology, respectively, at the University of Texas M.D. Anderson Cancer Center (MDACC). She is board certified by the American Board of Pathology in Anatomic Pathology, Clinical Pathology, Hematology and Molecular Genetic Pathology. Dr. Yin is an associate professor in the Department of Hematopathology at MDACC and an associate professor at UT Graduate School of Biomedical Sciences. In addition to clinical service and fellowship and postdoctoral education, Dr. Yin has been actively participating in multiple research projects in leukemia and lymphoma, which has led to over 50 research papers and editorial reviews, as well as 16 book chapters. She serves as members of editorial boards or reviewers for over 10 journals.

 Biography
Research Interest :

Mechanisms of imatinib resistance in patients with chronic myelogenous leukemia, Molecular monitoring of responses to kinase inhibitors in chronic myelogenous leukemia, Clinical, morphologic and molecular genetic features of acute myeloid leukemia, Immunoglobulin gene rearrangement in acute myeloid leukemia, Clinical, morphologic and molecular genetic features of a variety of lymphomas, Molecular markers as a tool in the diagnosis, targeted therapy and prognosis in cancer.
 

 Research Interest
 Network
Ming Tan

Ming Tan
Associate Professor
Center for Cell Death and Metabolism Research
Mitchell Cancer Institute
University of South Alabama
USA
Phone. 251-445-9853
Fax 251-460-6994

Biography :

Ming Tan, M.D., Ph.D., is an Associate Professor, an endowed research scholar, and the Director of Center for Cell Death and Metabolism Research at Mitchell Cancer Institute, University of South Alabama. Upon earning his Ph.D. degree in cancer biology from the University of Texas MD Anderson Cancer Center in 2000, he continued his research on the mechanisms of oncogene induced cancer progression and therapeutic resistance as a postdoctoral fellow. He joined the Faculty at Mitchell Cancer Institute at the University of South Alabama in 2007, where he directed a research program on metabolism and cancer, mechanism of cancer cell therapeutic resistance, invasion and metastasis, and microRNA in cancer development.

 Biography
Research Interest :

oncogene -mediated dysregulation of bioenergetic metabolism in cancer cells,breast cancer therapeutic resistance,signal transduction, and cancer progression/metastasis,metabolism and cancer,mechanism of cancer cell therapeutic resistance,and microRNA in cancer development.

 

 Research Interest
 Network
Yoh Dobashi

Yoh Dobashi
Associate Professor
Department of Pathology
Jichi Medical University
Japan
Tel. 814-864-04018

Biography :

Yoh Dobashi, graduated from Medical School in 1984, and Graduate School at Gunma University, Gunma, Japan, afterward. After the Hospital Residency and Research Fellowship in Yale University School of Medicine, USA, he has worked as Assistant Professor at the Department of Pathology, Faculty of Medicine, University of Tokyo until 1990. He has got involved in basic research for 3 years in Osaka University, moved to Department of Pathology, Kitasato University School of Medicine. Since 2006, he has been working in Department of Pathology, Saitama Medical Center, Jichi Medical University.  His major is pathological diagnosis and cell biology of lung cancer.

 Biography
Research Interest :
 Research Interest
 Network
Rachna Shroff

Rachna Shroff
Department of Gastrointestinal (GI) Medical Oncology
The University of Texas
USA

Biography :

The University of TexasDr. Rachna Shroff grew up in Arizona. She earned her Bachelor of Science degree in Biochemistry from Brown University in Providence, RI and went on to medical school at Jefferson Medical College in Philadelphia, PA. She moved to Washington University in St. Louis, MO for her Internal Medicine residency and Chief Residency before joining MD Anderson Cancer Center in Houston, TX, for her Medical Oncology fellowship. She subsequently joined the GI Medical Oncology faculty at MD Anderson where she specializes in treating pancreatic and biliary cancers and is focused on developing personalized, biomarker-driven therapies for these aggressive malignancies
 

 Biography
Research Interest :

Developing personalized, targeted therapy for biliary and pancreatic malignancies, molecular markers and biomarker development, novel pathways and therapies in gastrointestinal cancers.

 Research Interest
 Network
Michelle Fanale

Michelle Fanale
Department of Lymphoma/Myeloma
The University of Texas
USA
 

Biography :

Dr. Michelle A Fanale is an Assistant Professor in the Department of Lymphoma/Myeloma at The University of Texas MD Anderson Cancer Center in Houston, TX USA. She received her medical degree from the University of Medicine and Dentistry of New Jersey in Newark, NJ, USA. She completed her internal medicine residency at the Mayo Clinic in Rochester, MN, USA, followed by a fellowship in medical oncology and haematology at the MD Anderson Cancer Center.  Dr. Fanale focuses in caring for and clinical research for patients with Hodgkin lymphoma, T-cell lymphoma, Burkitt‘s and double-hit lymphomas, and HIV-associated lymphomas. In the field of Hodgkin lymphoma she has be a principal investigator (PI) for multiple clinical research trials, including for a series of trials with brentuximab vedotin (SGN-35) which has recently been FDA approved in August 2011 for treatment of relapsed and refractory classical Hodgkin and anaplastic large cell lymphoma. In addition she has recently completed a phase I trial and then a phase II trial evaluating bortezomib (B) plus ifosfamide, cyclophosphamide, etoposide (ICE) versus ICE for relapsed/refractory classical Hodgkin lymphoma. She also has an ongoing clinical classical Hodgkin lymphoma trial through Southwest Oncology Group (SWOG) evaluating the use of mid-treatment PET/CT scan results for stratification of front-line treatment intensity.

 Biography
Research Interest :

Furthermore, she is also interested in improving treatment strategies for patients with the rare diagnosis of nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) and has conducted a retrospective study evaluating outcomes with R-CHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisone) and has a under review with SWOG a phase II randomized protocol for patients with advanced stage NLPHL evaluating R-CHOP versus R-ABVD (Rituximab, Doxorubicin, Vinblastine, Dacarbazine). Her research has been presented at national and international meetings and her studies have been published in prestigious peer reviewed journals.

 Research Interest
 Network
M James You

M James You
Department of Hematopathology
The University of Texas
USA

Biography :

Dr. M. James You earned his PhD in Molecular and Cellular Biology from the University of Texas at Austin. His postdoctoral training was in the laboratory of Dr. Ronald A. DePinho at the Dana-Farber Cancer Institute, Harvard Medical School, where he studied PTEN and INK4a tumor suppressor genes in inhibiting the genesis of a variety of tumors. Dr. You obtained his medical degree from China, and underwent his clinic training in anatomic pathology and hematopathology at Brigham and Women’s Hospital, Harvard Medical School. Dr. You joined UT MD Anderson Cancer Center as an attending pathologist in 2006. His main clinic interest is hematopathology. Dr. You’s research laboratory focuses on cancer genetics and pathobiology, and translational pathology
 

 Biography
Research Interest :

Tumor suppressors
Genetically engineered mouse models
Translational pathology
My laboratory is interested in cancer biology and genetics as well as translational research. Our current focus is myeloid and lymphoid neoplasm using genetic and oncogenomic approaches to uncover important genetic events that may drive tumor initiation and progression. In addition, we complement basic mechanistic studies with translational research on human tumor specimens, which helps to correlate genetic changes, expression profiling, or other molecular signatures with clinical behavior and outcome.
 

 Research Interest
 Network
Chen S. Su

Chen S. Su
Department of Hematopathology
The University of Texas
USA
Tel. 713-792-2576
Fax 713-794-4773

Research Interest :
 Research Interest
 Network
Yumay Chen

Yumay Chen
Department of Medicine/Division of Endocrinology
University of California
USA
Read Interview session with Yumay Chen

Biography :

University of CaliforniaYumay Chen was born in Taiwan, in 1963. She received the Bachelor of Science degree from National Chung-Hsing University, Tai-Chung, Taiwanin 1987 and the PhD degree from the University of Texas Health Science at San Antonio, Texas, USA, in 1997. Her research has been focuses on the molecular and cellular basis of stress response pathways with the believe that a thoroughly understanding in these pathways will lead to a better understanding of the diseases that can arise when these pathways are tampered- such as cancers, cystic disease, diabetics, etc. She received Patricia Welder Robinson Young Investigator Award in 2002 and ASN Carl W. Gottschalk Research Scholar Award in 2003.  She current is an Assistant Professor at University of California, Irvine.
 

 Biography
Research Interest :

Cell cycle regulation, DNA damage response/repair, mitosis regulation, polycystic kidney disease.

 Research Interest
 Network
Xin Ming

Xin Ming
School of Pharmacy
University of North Carolina
USA

Biography :

Dr. Ming received his early training at the B.S and M.S. levels from China Pharmaceutical University and The University of Texas College of Pharmacy. In 2004 Xin began his PhD studies at The University of North Carolina School of Pharmacy. His thesis work with Prof. Dhiren Thakker dealt with mechanisms of transporter-mediated drug delivery. In 2008 Dr. Ming joined Prof. Rudy Juliano′s laboratory as a postdoctoral fellow to work on projects concerning targeted delivery of antisense and siRNA oligonucleotides and the underlying cell and molecular mechanisms. In 2011, he was appointed a Research Assistant Professor in the same university. Since then, he has extended his research to targeted delivery of oligonucleotide-based therapeutics for chronic kidney diseases and diabetes.

 Biography
Research Interest :

 Transporter-targeted drug delivery for tumors and kidney diseases treatment, Targeted delivery of oligonucleotide-based therapeutics for tumors, chronic kidney diseases and diabetes.

 Research Interest
 Network
Faiz Y. Bhora

Faiz Y. Bhora
Columbia University College of Physicians and Surgeons
USA
Tel. 212-523-7475
Fax 212-523-8011
 

Biography :

Faiz Y. Bhora, MD, FACS, is Assistant Clinical Professor of Surgery at Columbia University College of Physicians and Surgeons and Attending Thoracic Surgeon at St. Lukes-Roosevelt Hospital Center in New York.  He received his medical education from the Aga Khan University, Karachi, Pakistan, and his General Surgery training at the George Washington University Medical Center.  He received his training in Cardiothoracic Surgery at UCLA Medical Center, followed by a fellowship in Thoracic Oncology Surgery at The University of Pennsylvania. 

Dr. Bhora is an active member of the Association for Academic Surgery and the Society for University Surgeons (Co-Chair of the Leadership Committee), The Society of Thoracic Surgeons (Research Task Force), ITMIG (Workforce on Thymic Cancer) and the American College of Surgeons.  He is also founding member of the New York General Thoracic Surgery Club (NYGTSC) and of the New York chapter of the Young Fellows Association.  He is the recipient of several national awards, including Patient’s Choice Award for 2009-2011 and America’s Top Surgeons 2011. 

 Biography
Research Interest :

Dr. Bhora′s area of interest and specialty is Thoracic Oncology Surgery, involving complex lung resections and esophageal cancer.  He specializes in minimally invasive approaches to thoracic surgical disease and in the use of the Da Vinci robot to perform minimally invasive lung resections, esophageal resections, thymectomy for myasthenia gravis and resection of other mediastinal masses.  He is nationally known for his expertise in advanced bronchoscopic surgery involving the airway, including airway stenting for lung and thoracic cancer.  He has developed the largest interventional airway program in the region and frequently is able to offer treatment with excellent outcomes to even the most complex of patients.

 Research Interest
 Network
Jennifer J. Wu

Jennifer J. Wu
NYU Cancer Institute
USA
Tel. 212-263-6485

Biography :

Jennifer Wu grew up in Beijing, China and immigrated to Baltimore during high school, where her parents were visiting physician scientists at NIH and Johns Hopkins Medical Center. She then moved to New York City to finish high school. After getting a Bachelor’s Degree in Biochemistry at State University of New York at Binghamton, Jennifer returns to New York City to pursue a career in medicine at Albert Einstein College of Medicine. She decided to stay at Montefiore Medical Center for internship and residency in order to continue working with Dr. Janice Dutcher, who was her mentor and role model during medical school, and contributed to Jennifer’s decision to pursue hematology and oncology.  With the ever changing landscape of oncology and diverse patient population at NYU Langone Medical Center, Jennifer is delighted to stay as faculty after completion of her fellowship with a concentration on patients with hepatocellular carcinoma and biliary cancer.

 Biography
Research Interest :

Gastrointestinal cancers with a focus on liver cancer and biliary cancers.

Community outreach and early cancer detection and screening.

 Research Interest
 Network
Molinda D Kearns

Molinda D Kearns
Department of Biology
Concordia College
New York

Biography :

Concordia College Molinda Kearns received her BS in Biology from D’Youville College in Buffalo, NY, and her MS and Ph.D. in Molecular Biology and Pharmaceutical Sciences respectively from the Arnold and Marie Schwartz College of Pharmacy of Long Island University. She completed a post-doctoral fellowship in Molecular Oncology and Pathology from Albert Einstein College of Medicine in 2011. As of 2012 she is an Assistant Professor of Chemistry and Biology at Concordia College, NY.

 Biography
Research Interest :

Her research interests revolve around the design and physicochemical characteristics of lipid based carriers of genetic constructs for use as parenteral formulations. She has conducted in-depth work on cholesterol derived genetic carriers and their cell membrane trafficking.

 Research Interest
 Network
Longgui Wang

Longgui Wang
Medical Oncology
The NYU Cancer Institute
USA

Biography :

I was trained in pharmaceutical sciences and in medicine with extensive research experience in the field of molecular biology/pharmacology, oncology and immunology. In recent years, my major research interests are cancer molecular biology, cancer chemotherapy and prevention as well as immunology and autoimmune/autoinflammatory diseases. I am one of founders of Natrogen Therapeutics International, and a chief scientist and president of the company with an adjunct position at New York University School of Medicine since December 2006. I was an assistant professor at the New York University School of Medicine from 2003 to 2006 and at the Mount Sinai School of Medicine from 1996 to 2003. My postdoctoral training was at Brookhaven National Laboratory, and the Roswell Park Cancer Institute. I published over 60 peer-reviewed papers in scientific journals most of which I was listed as a senior author, appeared as a speaker at symposiums, and granted 6 patents in treating autoinflammatory diseases and cancer while many other patents are currently in pending.

 Biography
Research Interest :
 Research Interest
 Network
Rong Stephanie Huang

Rong Stephanie Huang
Department of Medicine
The University of Chicago
USA

Biography :

Dr. Huang is currently an Assistant Professor of Medicine; Director, the Pharmacogenomics of Anticancer Agents Research (PAAR) Cell Line Core; Member, Committee on Clinical Pharmacology and Pharmacogenomics, the University of Chicago Comprehensive Cancer Center, Center for Personalized Therapeutics, Committee on Cancer Biology at the University of Chicago. Dr. Huang is a member of American Association for Cancer Research (AACR), American Society of Human Genetics (ASHG) and American Society of Clinical Pharmacology and Therapeutics (ASCPT). She serves on the editorial board of Genomics, Proteinomics and Bioinformatics, and on Journal of Blood Disorders & Transfusion. She published more than 30 original research papers many of which are in high caliber journals, e.g., Nature Medicine, PNAS, Blood, Cancer Research and American Journal of Human Genetics.

 Biography
Research Interest :

My lab research focuses on translational pharmacogenomic research with particular interest in the pharmacogenomics of anticancer agents. By systematically evaluating the human genomes and their relationships to drug response and toxicity, our goal is to develop clinically useful models that predict risks for adverse drug reactions and non-response prior to administration of chemotherapy. We utilize cell lines (derived from healthy and disease individuals as well as commercially available cancer cell lines), and clinical samples to discover and functional characterize genetic variations, gene and microRNA (miRNA) expression for their role in chemotherapeutic sensitivity.

 Research Interest
 Network
Tapan K. Bera

Tapan K. Bera
Laboratory of Molecular Biology
National Cancer Institute
USA

Tel. 301 496-0976
Fax 301 402-1344

Biography :

Dr. Tapan Bera received his M.S. and PhD in Biochemistry from the Calcutta University, India. He completed his postdoctoral research training in the Cancer Research Laboratory, UC Berkeley and in the Laboratory of Molecular Biology, National Cancer Institute. Currently he held the Associate Scientist position at the National Cancer Institute, NIH, USA. His research objectives are focused mainly on to understand the molecular basis of cancer by identifying the genes involved in this process and translate that information to possible targeted therapy of cancer. Dr Bera has discovered several very interesting and important genes whose expression is restricted to normal prostate and prostate cancer and are now being developed as therapeutic targets for the treatment of prostate cancer. Dr Bera is author/co-author in more than 65 papers published in peer-reviewed journals.

 Biography
Research Interest :

Cancer biology and Immunotherapy

 Research Interest
 Network
Mark L. Schiebler

Mark L. Schiebler
Department of Radiology
University of Wisconsin-Madison
USA
Tel. 608-263-8821
Fax 608-263-0876

Biography :

I was born into a family of educators and have found that area of my life to be the most fulfilling along with being involved with innovative research in Computed Tomography and Magnetic Resonance Imaging. My clinical duties as the Chief of Thoracic imaging include coordinating the clinical care of chest imaging examinations on cancer patients and the supervision of academic staff, resident teaching, and medical student instruction for the Chest Section. The next ten years promise to be important for quantitative lung imaging and I hope to play an important role in translating the newest research methods into clinically useful protocols.

 Biography
Research Interest :

Coronary Artery CTA
Magnetic Resonance MRA
Pulmonary Artery Hypertension
Pulmonary Embolism
Hyperpolarized Gas MR Ventilation Imaging
 

 Research Interest
 Network
Amit K. Maiti

Executive Editor
Amit K. Maiti
Genetic epidemiology Unit
Department of A & I
Oklahoma Medical Res Foundation
USA
Tel. 405-271-8099
Read Interview session with Amit K. Maiti

Biography :

I did PhD in yeast Molecular biology from Jadavpur University (Bose Institute), Kolkata, India. My postdoctoral studies comprised on genetics of left-right asymmetry in human in CRBM, France and Geneva University of Medical School in Switzerland with Prof P. Bouvagnet and Prof. Stylianos E. Antonarakis respectively. Then I moved to USA and worked on genetics and drug discovery in ovarian and lung cancer in University of Texas Medical Branch, Galveston with Prof. S. Mitra. Now I am a senior research scientist at OMRF, Oklahoma city and continue to work on genetics and drug discovery of autoimmune diseases, cancer and cardiovascular diseases. Multidrug resistance in cancer is a overwhelming problem in cancer and I developed a novel strategy to overcome drug resistance in cancer.

 Biography
Research Interest :

Population genetics, Genomics, System biology, Molecular biology of disease mechanism and drug development of autoimmune diseases, Cancer and Cardiovascular diseases.

 Research Interest
 Network
Gengyun Wen

Gengyun Wen
Center for Radiation Research
Columbia University Medical Center
USA

Tel. 212-305-9981
Fax 212-305-3229
 

Biography :
 Biography
Research Interest :
 Research Interest
 Network
Mojtaba Akhtari

Executive Editor
Mojtaba Akhtari
Division of Hematology and Oncology
University of Nebraska Medical Center
Omaha, USA
Tel. 402-559-3834
Fax. 402-559-6520
Read Interview session with Mojtaba Akhtari

Biography :

Dr. Mojtaba Akhtari is an Assistant Professor in the Department of Internal Medicine, Division of Hematology and Oncology at the University of Nebraska Medical Center. He earned his medical degree from Tehran University of Medical Sciences in Tehran, Iran. Then, he moved to England, where he received training in internal medicine and hematology. He served in the Department of Hematological Medicine, King’s College Hospital in London, England. He moved to Evanston, Illinois, USA, where he completed his residency in internal medicine at Saint Francis Hospital of Evanston, and he also received Humanism in Medicine Award. He undertook fellowship training in hematology and medical oncology at Winship Cancer Institute, Emory University School of Medicine in Atlanta, Georgia, and during this time he specialized in the management of benign and malignant hematological disorders, stem cell transplantation, and solid tumors. He is board certified in Internal medicine, Hematology and Medical Oncology. He is an active member of the American Society of Hematology (ASH), American Society of Clinical Oncology (ASCO) and American Society for Blood and Marrow Transplantation (ASBMT). Dr. Akhtari is a member of the Chronic Myeloid Leukemia Panel of the National Comprehensive Cancer Network (NCCN).

 Biography
Research Interest :

Acute and chronic leukemias as well as myelodysplastic syndromes, therapy-related myeloid neoplasms, familial leukemias, immune cytopenias, and bone marrow transplantation.

 Research Interest
 Network
Jue Wang

Jue Wang
The Genitourinary Oncology
University of Nebraska Medical Center
USA
 

Biography :

Upon completion of Medical degree and Postgraduate training in 1993 in China, Dr. Wang joined the faculty at SuZhou Medical School where his main clinical research on molecular biology of brain tumor. In 1994, Dr Wang was a visiting Scientist at The Institute of Cancer Research /Royal Marsden Hospital, England. In 1995, Dr. Wang relocated to Texas where he completed his post-doctoral fellowship, subsequently clinical training including Hyperbaric Medicine/Surgical Infectious disease, Internal Medicine Residency, Medical Oncology Fellowship at the University of Texas Medical Branch. Dr. Wang joined the faculty in Department of Internal Medicine, Division of Hematology/Oncology at the University of Nebraska in 2007. Dr Wang is the director of the genitourinary oncology program of the division of oncology-hematology at University of Nebraska Medical Center.

 Biography
Research Interest :

His current clinical interest includes Genitourinary Malignancies, Geriatric oncology and Cancer of unknown primary. He is the Principal Investigator of several ongoing clinical trials.

 Research Interest
 Network
Kamalesh Kumar Sankhala

Kamalesh Kumar Sankhala
Cancer Therapy and Research Center
University of Texas
USA
Tel. 210-450-5956
Fax 210-692-7502

Biography :

Dr Kamalesh Sankhala has received his medical degree (MD) and residency training in Internal Medicine from University of Rajasthan, India and Fellowship in Medical Oncology from University of Texas Health Science Center San Antonio, Texas. Currently he is working as a clinical investigator at the Institute for Drug Development (IDD), Cancer Therapy and Research Center of The University of Texas Health Science Center at San Antonio. Since 2003 Dr. Sankhala has been working in the area of Oncology Drug Development Research. IDD is known for being the largest Oncology drug development research program in the United States and has set unprecedented standards for the development of novel anti-cancer agents, playing a key role in the preclinical and clinical development of 20 new cancer drugs that were subsequently approved by the Food and Drug Administration (FDA). Since he joined IDD in 2006, Dr. Sankhala has worked as clinical investigator on about 22 investigational clinical studies on novel anti-cancer drugs; additionally he has been a sub-investigator on 80 other clinical studies. Dr. Sankhala’s research focuses on translational research of novel anti-cancer agents and on studying the pre-clinical and clinical aspect of these agents.

 Biography
Research Interest :

His clinical experties include management of patients with Sarcoma.  He is the recipient of American Society of Clinical Oncology Foundation Merit Award and AACR-NCI scholarship for Molecular Biology in Clinical Oncology. He has authored several research articles and is a reviewer of reputed Journals in the field of oncology.   

 Research Interest
 Network
Ekokobe Fonkem

Ekokobe Fonkem
Director
Department of Neurology
Brain Tumor Center
Division of Neuro-Oncology
Scott & White Healthcare, USA
Tel. 254-724-4179
Fax 254-724-5766
Read Interview session with Ekokobe Fonkem

Biography :

Dr. EkokobeFonkemis currently an assistant professor of Medicine at Texas A&M University Health Science Center College of Medicine and Director of the Brain Tumor Center at Baylor Scott & White Health Care. He completed his undergraduate degree in Biochemistry at the University of Wisconsin- Madison in 2002. He received his DO degree at the Ohio University Heritage College of Osteopathic Medicine in 2007 and went on to complete internship and neurology residency training at Ohio State University Medical Center in Columbus, OH, followed by Neuro-Oncology Fellowship at Harvard University Beth Israel Deaconess Medical Center in Boston, MA. He has authored and co-authored numerous articles on brain tumors and neurological complications associated with brain tumors. He maintained members with the American Academy of Neurology, Society of Clinical Oncology and Society of Neuro-Oncology.

 Biography
Research Interest :

Dr. EkokobeFonkemis research areas include neurological complications of primary brain tumors and metastatic brain tumors, both immunological and metabolic therapies for the treatment of these tumors. He has also interested in quality of life issues in patients with brain tumors.

 Research Interest
 Network
Christine Brezden-Masley

Christine Brezden-Masley
Department of Medicine
University of Toronto
Canada

Biography :

Dr. Christine Brezden-Masley achieved all of her training in Toronto. She completed her PhD in Medical Biophysics at the Ontario Cancer Institute, Princess Margaret Hospital and her MD degree subsequently at the University of Toronto. She completed her Medical Oncology training in Toronto including research with the Investigational New Drug Development program. She currently is appointed at the University of Toronto as an Assistant Professor and is a Staff Medical Oncologist at St. Michael′s Hospital where she specializes in treating both Breast and GI Malignancies.

She is very active in clinical research and holds a CIHR grant studying cardiotoxicity from breast cancer therapy. She is the Head of the Oncology Clinical Research Group, where more than 20 clinical cancer trials are open at SMH and currently accruing patients. She is also the Founder of the COMET (Community Oncologists of Metropolitan Toronto) Clinical Trials Consortium, a virtual community providing access for cancer patients to appropriate cancer clinical trials.
 

 Biography
Research Interest :

Her research includes studying the molecular pathways in breast and gastric tumorigenesis. She is cross-appointed to the LiKaShing Knowledge Translation Center where she is serves as an oncology specialist for current and future studies. In addition to clinical research, she also has a focus on patient safety and quality improvement as it pertains to cancer delivery at the academic cancer centers at the University of Toronto.

 Research Interest
 Network
Alan L. Parker

Alan L. Parker
University of Glasgow
Glasgow, UK

Biography :
 Biography
Research Interest :

My main area of research is in gene therapeutics and gene/drug targeting especially in relation to phage display

 Research Interest
 Network
Shouji Shimoyama

Shouji Shimoyama
Gastrointestinal Unit
Settlement Clinic
Japan

Biography :

Dr. Shouji Shimoyama graduated from University of Tokyo in 1987, and has been engaged in clinical practice of upper gastrointestinal surgery and endoscopy. He got a position of a research fellow in the Department of General Surgery, University of Ulm in Germany (1994-1996), followed by an Assistant Professor in the Department of Gastrointestinal Surgery, University of Tokyo. He is currently a Director of Settlement Clinic in Tokyo since 2008, and a member of adjunct teaching staff of Department of Gastrointestinal Surgery, University of Tokyo. He has published over 50 peer-reviewed papers and has been an author of 3 book chapters. His research topic is esophageal and gastric oncology, upper gastrointestinal endoscopy, and pharmacogenetics on the oncological point of view. He has served on the Editorial Board of several journals in the field of gastroenterology.

 Biography
Research Interest :
 Research Interest
 Network
Gerhard Putz

Gerhard Putz
Department Clinical Chemistry
University Freiburg Medical Center
Germany
Read Interview session with Gerhard Putz

Biography :
 Biography
Research Interest :

•    CARL – and Kinetic Targeting: How to diminish side effects of anticancer drug delivery
•    Pharmacokinetics and body distribution of particle based anticancer drugs
•    Phosphatidylcholines, mere innocent bystanders? – Interference of liposomal phosphatidycholines with proliferation of cancer cells
•    Phospholipid and lipoprotein metabolism
•    Lipid analysis by LC-MS/MS
•    In silico modelling of lipoprotein metabolism
•    Thrombocyte specific contrast agents for MRI-imaging
•    Liver specific contrast agents for MRI-imaging
•    Therapeutic drug monitoring during chemotherapy
 

 Research Interest
 Network
Uwe F. Pliquett

Uwe F. Pliquett
Institut für Bioprozess- und Analysenmesstechnik
Heilbad Heiligenstadt
Germany
Read Interview session with Uwe F. Pliquett

Biography :

Uwe F. Pliquett received the diploma degree in electronic instrumentation and the Dr.-Ing. degree in measurement techniques in 1988 and 1991, respectively, from the Engineering College Mittweida, Germany. From 1993 to 1996 he was postdoctoral fellow at MIT, Cambridge, MA, working on transdermal drug delivery mediated by pulsed electric field.  He continued the work on electroporation and bio-impedance measurements at the University of  Bielefeld / Germany, where he received the habilitation in 2000. During 2005 he worked at Old Dominion University in Norfolk, VA, for investigation of changes in biological material due to the application of pulsed electric field. In 2006 he joined the Institut für Bioprozess- und Analysenmesstechnik, Heilbad Heiligenstadt, Germany, where he is currently working on characterization and manipulation of biological material using electrical and optical methods. 

 Biography
Research Interest :

Transdermal drug delivery mediated by pulsed electric field.

 Research Interest
 Network
Luca Arcaini

Luca Arcaini, MD
Department of Oncohematology
University of Pavia
Italy
Tel. 390-382-501-308
Fax 390-382-502-250

Biography :

Luca Arcaini is Assistant Professor of Hematology at University of Pavia School of Medicine, Pavia, Italy and is Attending Physician of Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia. He is in charge of clinical research programs and experimental protocols for indolent non-Hodgkin’s lymphomas.

 Biography
Research Interest :

His research is the focused on the definition of the relationship among lymphoma and hepatitis C virus chronic infection, with collaborative and autonomous studies and in clinico-pathological, biological and prognostic characterization of novel clinical entities, in particular marginal zone-related neoplasms. Luca Arcaini chaired a national project entitled Margianl zone Project (2003-2006). This project collected the largest series of splenic marginal zone patients publishes so far (Blood 2006) and permitted to develop a prognostic score for clinical use. His research activity is also aimed to experimentation of novel modalities of treatments combining anti-CD20 monoclonal antibody and chemotherapy (immunochemotherapy) with an original  clinical and pharmacokinetic model of immunochemotherapy, in vivo purging and lymphoma-free peripheral progenitors cells.

 Research Interest
 Network
Alexandre Muehlmann

Alexandre Muehlmann
University of Brasilia
Brazil

Biography :

Luis Alexandre Muehlmann is a postdoc researcher at the University of Brasília and at the Nanodynamics Company. His research interests lie in the area of nanostructured delivery-systems for antineoplastic agents and vaccines. Muehlmann completed his PhD at University of Brasília and his undergraduate studies at Federal University of Paraná.

 Biography
Research Interest :

In recent years he has focused on the development of new nanocarriers for photosensitizers used in antineoplastic photodynamic therapy, as well as nanostructured immunoadjutants for specific immunotherapy. His former field of research was the analysis of the effects of fatty acids on the immune system.

 Research Interest
 Network
Marina Nikitovic

Marina Nikitovic
Institute for Oncology and Radiology
Pasterova
Serbia

Biography :

Dr. Marina Nikitovic received her education in Belgrade, Serbia. She graduated from The Faculty of Medicine, University of Belgrade in 1984. She has been working at The Institute for Oncology and Radiology of Serbia, which is also a National Cancer Research Centre, since 1987. After specialising in Radiology in 1991, she worked as a radiation oncologist in the Paediatrics Department. In the year 2000, she became the Head of the Radiotherapy Department. From the beginning of her career, she has been very involved in neuro-oncology, which is still her main clinical interest. Her PhD thesis, completed in 2001, is in this field, as well. She is the chairman of the Brain Tumours Committee at the Institute. She is also an assistant professor of Radiation Oncology for undergraduates and postgraduates at the Faculty of Medicine. In addition, she is a Mentor for Brain tumours, Hodgkin’s lymphoma, Bone tumours and Paediatric Radiation Oncology.
 

 Biography
Research Interest :

Neuro-oncology

 Research Interest
 Network
Shu Liu

Shu Liu
Associate professor
Thoracic Oncology Lab
University of california

 

Biography :

\r\n

\r\n

Shu Liu joined the Thoracic oncology lab in Oct., 2012 as a postdoctoral fellow. Her main research interest here is small molecule drug development. She works on several of exciting drug discovery projects using computational chemistry methods to rationally design, optimize properties of drug candidates and predict ADMET profiles. She also characterizes compounds to understand their activities both in vitro and in vivo.

\r\n

Liu has a Ph.D. in pharmaceutical sciences from College of Pharmacy, University of South Carolina in 2012. She received her Ph.D training from her advisor Dr. Campbell McInness in the drug design and synthesis lab. Liu\s dissertation is entitled design of non-ATP competitive and cell cycle specific CDK inhibitors targeting cyclin binding groove.

\r\n

She also has a B.S. in biological sciences from University of Science and Technology of China in 2005. Her college research work was about transdermal drug delivery.

\r\n

 

 Biography
Research Interest :

Her main research interest here is small molecule drug development. She works on several of exciting drug discovery projects using computational chemistry methods to rationally design, optimize properties of drug candidates and predict ADMET profiles. She also characterizes compounds to understand their activities both in vitro and in vivo

 Research Interest
 Network
JAYANTHI REPALLI

JAYANTHI REPALLI
Varick Street
NYU Langone Medical Center
USA

Biography :

Jayanthi Repalli is a postdoctoral fellow at the NYU Langone Medical Center. Her research interests lie in the areas of drug design and development by using computational and invivo/invitro techniques. She has identified targets, discovered lead molecules, and optimized them for Alzheimer’s disease and Cancer by using virtual ligand and biochemical screening methodologies. She has graduated from University of South Carolina in 2011 with a doctoral degree in Pharmaceutical Sciences. Her doctoral thesis is entitled “Computational and Pharmacological Approaches to Design Allosteric Thymidylate Synthase Inhibitors.” She also has a Bachelors degree in Pharmacy from G. Pulla Reddy College of Pharmacy in India. Additionally, she is actively involved in consulting projects and provides subject matter expertise to early stage life science investors and entrepreneurs.

 Biography
Research Interest :

Small molecular drug design, Cancer biology, Computer aided drug design, Alzheimer’s disease, and Drug resistance

 Research Interest
 Network
Joydeep Mukherjee

Joydeep Mukherjee
Brain Tumor Research Centre
Hellen Diller Family Comprehensive Cancer Centre University of California
San Francisco

Biography :


 Biography
Research Interest :
 Research Interest
 Network

Dr. A. Heidari
Faculty of Chemistry
California South University
USA

Biography :

Dr. A. Heidari, Ph.D., D.Sc. is a Postdoctoral Research Fellow in Chemistry. He has got his Ph.D. and D.Sc. degrees form California South University (CSU), Irvine, California, USA. Furthermore, he has double postdocs in Project Management and also in Nanochemistry and Molecular Structure Theory. His research interests are Biophysical Chemistry, Nanochemistry, Quantum Chemistry, Biomolecular and Vibrational Spectroscopy, Molecular Modeling and Structure, Theoretical, Computational and Mathematical Chemistry, Ab initio and Density Functional Methods. He has participated at more than fifty reputed international conferences, seminars, congresses, symposiums and forums around the world as yet. Also, he possesses many published articles in Science Citation Index (SCI)/International Scientific Index (ISI) Journals. It should be noted that he has visited many universities or scientific and academic research institutes in different countries such as United States, United Kingdom, Canada, Netherlands, Russia, France, Swiss, Germany, Sweden, Spain, Portugal, South Korea, China, etc. as research fellow, sabbatical and volunteer researcher or visitor heretofore. He has a history of several years of teaching for college students and various disciplines and trends in different universities. Moreover, he has been a senior advisor in various industry and factories. He is expert in many computer programs and programming languages. Hitherto, he has authored more than ten books in Chemistry. Syne, he has been awarded more than two hundreds reputed international awards, prizes, scholarships and honors. Heretofore, he has multiple editorial duties in many reputed international journals. Hitherward, he is a member of more than one hundred reputed international academic–scientific–research institutes around the world.

 Biography
Research Interest :

Biophysical Chemistry,Biomolecular Spectroscopy, Quantum Chemistry, Nanochemistry, Theoretical Chemistry, Mathematical Chemistr, Computational Chemistry, Vibrational Spectroscopy, Molecular Modelling, Ab initio & Density Functional Methods, Molecular Structure

 Research Interest
 Network

Jon Ver Halen
Associate Professor
Department of Surgery
Texas A&M University School of Medicine
USA

Biography :

Dr. Jon P. Ver Halen is currently an Associate Professor with the Texas A&M School of Medicine, Department of Surgery. He is also Associate Program Director of the Plastic Surgery Residency, and Program Director of the Microvascular Surgery Fellowship.

 Biography
Research Interest :

Cancer, Plastic surgery

 Research Interest
 Network
 
 
 
OMICS International Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
 
 
OMICS International Conferences 2016-17
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings
 
 

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

agrifoodaquavet@omicsinc.com

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

clinical_biochem@omicsinc.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@omicsinc.com

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

chemicaleng_chemistry@omicsinc.com

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

environmentalsci@omicsinc.com

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

engineering@omicsinc.com

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

generalsci_healthcare@omicsinc.com

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

genetics_molbio@omicsinc.com

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immuno_microbio@omicsinc.com

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

omics@omicsinc.com

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

materialsci@omicsinc.com

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

mathematics_physics@omicsinc.com

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

medical@omicsinc.com

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuro_psychology@omicsinc.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

pharma@omicsinc.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@omicsinc.com

1-702-714-7001 Extn: 9042

 
© 2008-2016 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version